The dealmakers had extra time on their hands this winter.
Announced U.S. mergers and acquisitions slipped 20 percent in January, February and March to 2,623 from 3,282 in the fourth quarter of 2012, which was the best quarter for deals since the 2008-09 recession.
"Higher taxes and uncertainty pulled things forward into the fourth quarter of 2012," said Tim DeVries, managing general partner at Norwest Equity Partners, the region's largest private equity investor. "The first quarter was very slow. There was less inventory."
The number of deals involving Minnesota-based investment bankers slid from 107 in the fourth quarter to 44 in the first quarter of this year. The drive to finish deals late last year was hastened by the December fiscal-cliff debate and the rise of long-term capital gains rates for affluent investors.
Taxes on dividends and long-term capital gains remained the same for most taxpayers, but for high-income earners and couples, the tax on gains from investments held for more than a year rose from 15 percent to 20 percent in 2013.
The slowdown in the M&A market crimped the income statements of some dealmakers. For example, Minneapolis-based Piper Jaffray reported earlier this month increased profitability thanks to cost-cutting measures it took last year and a surging stock market that was good for its fee-based asset management business. But revenue was restrained by the slower deal pipeline.
But there were a number interesting first-quarter transactions, including:
• Plymouth-based Mardil Medical raised $6.124 million in equity, in a pretty soft venture capital market, about $5 million of which came from a Malaysian venture fund chartered by the Malaysian government. Minneapolis-based LifeScience Alley, the regional trade group, made the connection for Mardil through its international network.